Risk assessment of the adverse impact of industrial synthesis of benzodiazepine drugs on human health

Among the occupational and work-related diseases of employees in pharmaceutical industry the leading positions belong to the diseases caused by long-term work under the conditions of relatively low concentrations of hazard substances. The study and evaluation of risks will eliminate or reduce the im...

Full description

Saved in:
Bibliographic Details
Main Authors: L. G. Gorokhova, D. V. Surzhikov, N. N. Mikhailova, N. A. Martinova
Format: Article
Language:Russian
Published: Scientific Сentre for Family Health and Human Reproduction Problems 2013-05-01
Series:Acta Biomedica Scientifica
Subjects:
Online Access:https://www.actabiomedica.ru/jour/article/view/1490
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849251589624168448
author L. G. Gorokhova
D. V. Surzhikov
N. N. Mikhailova
N. A. Martinova
author_facet L. G. Gorokhova
D. V. Surzhikov
N. N. Mikhailova
N. A. Martinova
author_sort L. G. Gorokhova
collection DOAJ
description Among the occupational and work-related diseases of employees in pharmaceutical industry the leading positions belong to the diseases caused by long-term work under the conditions of relatively low concentrations of hazard substances. The study and evaluation of risks will eliminate or reduce the impact, thereby, enhancing the quality of life. Synthetic drugs - benzodiazepine derivatives by the values of middle-lethal doses are substances of the 111 class of hazard and cause slight irritating effect to the skin and mucous membranes of the eyes; skin-resorptive and sensitizing effects have not been identified. For the studied benzodiazepine derivatives the safe exposure levels have been approved in the following values: nozepam -1 mg/m3; mezapam - 0.3 mg/m3; sibazon - 0.2 mg/m3; alprazolam - 0.1 mg/m3. On the base of the toxicological studies the parameters of the hazardous effects on the body have been identified allowing for a final risk characterization. The article presents the results of the calculation of the potential dose that may be received by the employee during the working shift in the synthesis of products of this series. Calculation of safe level of exposure is based on a threshold concentration of substances. Drags risk factors by inhalation have been calculated by comparing the value of the potential dose of a xenobiotic received for one shift by inhalation with its level of safe effect under the same route of exposure. The estimated hazard ratios for the studied substances demonstrate a low probability of adverse effects on the workers during the production of nozepam and alprazolam. High risk of negative impact on the health of workers has been identified during the production of sibazon and mezapam. This information can then be used to control the working environment during the synthesis of drugs - benzodiazepine derivatives, aimed at creating a safe working environment and, consequently, improving the workers' life quality.
format Article
id doaj-art-b8008e66658e4fe8b6fb12ed4f68d72f
institution Kabale University
issn 2541-9420
2587-9596
language Russian
publishDate 2013-05-01
publisher Scientific Сentre for Family Health and Human Reproduction Problems
record_format Article
series Acta Biomedica Scientifica
spelling doaj-art-b8008e66658e4fe8b6fb12ed4f68d72f2025-08-20T03:56:54ZrusScientific Сentre for Family Health and Human Reproduction ProblemsActa Biomedica Scientifica2541-94202587-95962013-05-0103(2)57591436Risk assessment of the adverse impact of industrial synthesis of benzodiazepine drugs on human healthL. G. Gorokhova0D. V. Surzhikov1N. N. Mikhailova2N. A. Martinova3ФГБУ «Научно-исследовательский институт комплексных проблем гигиены и профессиональных заболеваний» СО РАМНФГБУ «Научно-исследовательский институт комплексных проблем гигиены и профессиональных заболеваний» СО РАМНФГБУ «Научно-исследовательский институт комплексных проблем гигиены и профессиональных заболеваний» СО РАМНФГБУ «Научно-исследовательский институт комплексных проблем гигиены и профессиональных заболеваний» СО РАМНAmong the occupational and work-related diseases of employees in pharmaceutical industry the leading positions belong to the diseases caused by long-term work under the conditions of relatively low concentrations of hazard substances. The study and evaluation of risks will eliminate or reduce the impact, thereby, enhancing the quality of life. Synthetic drugs - benzodiazepine derivatives by the values of middle-lethal doses are substances of the 111 class of hazard and cause slight irritating effect to the skin and mucous membranes of the eyes; skin-resorptive and sensitizing effects have not been identified. For the studied benzodiazepine derivatives the safe exposure levels have been approved in the following values: nozepam -1 mg/m3; mezapam - 0.3 mg/m3; sibazon - 0.2 mg/m3; alprazolam - 0.1 mg/m3. On the base of the toxicological studies the parameters of the hazardous effects on the body have been identified allowing for a final risk characterization. The article presents the results of the calculation of the potential dose that may be received by the employee during the working shift in the synthesis of products of this series. Calculation of safe level of exposure is based on a threshold concentration of substances. Drags risk factors by inhalation have been calculated by comparing the value of the potential dose of a xenobiotic received for one shift by inhalation with its level of safe effect under the same route of exposure. The estimated hazard ratios for the studied substances demonstrate a low probability of adverse effects on the workers during the production of nozepam and alprazolam. High risk of negative impact on the health of workers has been identified during the production of sibazon and mezapam. This information can then be used to control the working environment during the synthesis of drugs - benzodiazepine derivatives, aimed at creating a safe working environment and, consequently, improving the workers' life quality.https://www.actabiomedica.ru/jour/article/view/1490risk assessmenthuman healthbenzodiazepine drugs
spellingShingle L. G. Gorokhova
D. V. Surzhikov
N. N. Mikhailova
N. A. Martinova
Risk assessment of the adverse impact of industrial synthesis of benzodiazepine drugs on human health
Acta Biomedica Scientifica
risk assessment
human health
benzodiazepine drugs
title Risk assessment of the adverse impact of industrial synthesis of benzodiazepine drugs on human health
title_full Risk assessment of the adverse impact of industrial synthesis of benzodiazepine drugs on human health
title_fullStr Risk assessment of the adverse impact of industrial synthesis of benzodiazepine drugs on human health
title_full_unstemmed Risk assessment of the adverse impact of industrial synthesis of benzodiazepine drugs on human health
title_short Risk assessment of the adverse impact of industrial synthesis of benzodiazepine drugs on human health
title_sort risk assessment of the adverse impact of industrial synthesis of benzodiazepine drugs on human health
topic risk assessment
human health
benzodiazepine drugs
url https://www.actabiomedica.ru/jour/article/view/1490
work_keys_str_mv AT lggorokhova riskassessmentoftheadverseimpactofindustrialsynthesisofbenzodiazepinedrugsonhumanhealth
AT dvsurzhikov riskassessmentoftheadverseimpactofindustrialsynthesisofbenzodiazepinedrugsonhumanhealth
AT nnmikhailova riskassessmentoftheadverseimpactofindustrialsynthesisofbenzodiazepinedrugsonhumanhealth
AT namartinova riskassessmentoftheadverseimpactofindustrialsynthesisofbenzodiazepinedrugsonhumanhealth